Delivery Order SPE2DR25D1202-SPE2DR26F74CC
Award Date 1/16/26
Potential Completion Date 1/20/26
Potential Value $2.1K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $2,442.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Quillivant XR 25 mg/5 ml suspension (120 ml), with an ultimate completion date of October 24, 2025. This non-set-aside contract represents a competitively awarded delivery order under AmerisourceBergen's existing pharmaceutical supply vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a $2,311.74 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Quillivant XR 25 mg/5 mL suspension (60 mL) on January 12, 2026, with completion targeted for January 13, 2026. This delivery order is a non-set-aside contract executed under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031. The IDC serves as a comprehensive...
- The Defense Logistics Agency awarded a competitive delivery order valued at $1,971.30 to AmerisourceBergen Drug Corp for the supply of Quillivant XR 25 mg/5 ml suspension in 120 ml quantities. The award, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a firm fixed price transaction with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $1,188.34 to AmerisourceBergen Drug Corp for the supply of Quillivant XR 25 mg/5 ml suspension in 60 ml quantities. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by January 12, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor on this award through its corporate office division. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,043.22 to AmerisourceBergen Drug Corp for Quillivant XR 25 mg/5 ml suspension (120 ml), with an ultimate completion date of November 5, 2025. This firm fixed price delivery order, awarded on November 4, 2025, represents a competitively awarded contract with no set-aside designation. The product will be performed at the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $1,030.10 delivery order to AmerisourceBergen Drug Corp for Quillivant XR 25 mg/5 ml suspension (180 ml), with an ultimate completion date of December 11, 2025. This is a firm fixed-price, non-set-aside contract utilizing a competitive award process. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal healthcare vendor that supplies a comprehensive portfolio of medications and medical...
- The Defense Logistics Agency awarded a delivery order valued at $6,031.38 to AmerisourceBergen Drug Corp for the supply of Quillivant XR 25 mg/5 mL suspension (120 mL) on August 13, 2025, with an ultimate completion date of August 14, 2025. This contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. The pharmaceutical product will be delivered to the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $2,648.22 firm fixed price delivery order to AmerisourceBergen Drug Corp for Quillivant XR 25 mg/5 ml suspension (120 ml), with an ultimate completion date of November 5, 2025. This non-set-aside contract represents a single pharmaceutical delivery under the company's broader federal supply arrangements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $2,497.50 by the Defense Logistics Agency to supply Quillivant XR 25 mg/5 ml oral suspension (180 ml) for military and federal healthcare needs. The award was made on January 2, 2026, with an ultimate completion date of January 5, 2026, under a firm fixed-price contract with no set-aside designation. This delivery order represents a competitive award under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,282.59 firm fixed price delivery order to AmerisourceBergen Drug Corp for Quillivant XR 25 mg/5 mL suspension in 60 mL quantities, with completion targeted for December 10, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract (IDC) vehicle with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The product will be...